Join
Live feed
·
INSIDERFilingvia Quantisnow
Paratek Pharmaceuticals Inc. logo

SEC Form 4: Brenner Randall B. sold $12,201 worth of shares (3,516 units at $3.47) as part of a pre-agreed trading plan, decreasing direct ownership by 0.98% to 354,133 units (for withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.
PRTK· Paratek Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PRTK (Paratek Pharmaceuticals Inc.) and more on Quantisnow.